Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk
ثبت نشده
چکیده
Adopted by CHMP 15 November 2007 Date for coming into effect 31 May 2008 Draft agreed by Cardiovascular Working Party 28 March 2012 Adopted by CHMP for release for consultation 14 May 2012 Start of public consultation 30 May 2012 End of consultation (deadline for comments) 30 November 2012 Agreed by Cardiovascular Working Party 27 March 2013 Adopted by CHMP 30 May 2013 Date for coming into effect 30 November 2013
منابع مشابه
Epidemiology, diagnosis and treatment of pulmonary thromboembolism: review article
High incidence and mortality rate of pulmonary thromboembolism urge physicians to be aware of its occurrence and treatment. Pulmonary thromboembolism (PE) typically manifests itself with acute dyspnea and tachycardia and may occur along with deep vein thrombosis. However, syncope, chest pain and heart failure decompensation in previously stable patients might be another presenting signs and sym...
متن کاملComparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial
Venous thromboembolism (VTE) occurs in about 5 percent of patients undergoing major abdominal surgeries. Prophylaxis of VTE is recommended using unfractionated heparin (UF) or low molecular weight heparin (LMWH) in high-risk patients. In spite of advantages and confirmed cost-effectiveness of LMWH, high costs of enoxaparin branded preparations limit its use. We aimed to compare the efficacy and...
متن کاملComparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial
Venous thromboembolism (VTE) occurs in about 5 percent of patients undergoing major abdominal surgeries. Prophylaxis of VTE is recommended using unfractionated heparin (UF) or low molecular weight heparin (LMWH) in high-risk patients. In spite of advantages and confirmed cost-effectiveness of LMWH, high costs of enoxaparin branded preparations limit its use. We aimed to compare the efficacy and...
متن کاملChapter 12 Coagulation, Thromboembolism, and Blood Management in Orthopaedic Surgery
Venous thromboembolic disease and prophylaxis are subjects of controversy in orthopaedic surgery. Venous thromboembolism is a major risk in patients undergoing total hip and knee arthroplasty as well as repair of a hip fracture. In addition, patients sustaining major orthopaedic trauma including spinal cord injury as well as patients undergoing treatment of various other musculoskeletal conditi...
متن کاملNICE guidelines on reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing surgery
r c 200 3 u.ac.uk Summary Venous thromboembolism (VTE) is most preventable and unacceptably over 25,000 people die of VTE annually in England. The scale of VTE mortality prompted the UK Department of Health to charge the National Institute for Health and Clinical Excellence (NICE) with the task of developing a national guideline for ‘‘reducing the risk of VTE in high risk surgical patients’’. T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013